Penny Stocks To Buy [or sell] #5: Immutep
Immutep Ltd. (IMMP – Free Report) saw share volume jump on Wednesday with prices reaching highs of $2.40 before the lunch hour. Over the last 3 weeks, the penny stock has seen a boost in daily average trading volumes as well as an increase in its share price. On January 29 the penny stock hit new highs after releasing an update to shareholders.
Immutep reported on the development of its product candidates. These included IMP321 and IMP761. For its IMP321, the company is preparing to give its first data from late-stage AIPAC study in metastatic breast cancer. The anticipated date is sometime in March of this year. According to the company, “If positive, AIPAC results could help to validate an entirely new class of products in immuno-oncology: antigen-presenting cell activators, along with the ‘pushing the gas’ concept.”
“This would be a landmark medical achievement, with metastatic breast cancer just being the first indication of possibly many others to follow. It would also arm the Company with the data it needs to make strategic decisions, paving the way for the creation of very significant value for Immutep and its shareholders.”
